Translation initiation and viral tricks

Trends in Biochemical Sciences

Volumn 28, Issue 3, 2003, Pages 130-136

  Schneider, Robert J ^a   Mohr, Ian ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GENE PRODUCT; INITIATION FACTOR; INITIATION FACTOR 4F; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL FATE; COMPETITION; DNA VIRUS; GENE FUNCTION; GENETIC PROCEDURES; HOST CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA VIRUS; TRANSLATION INITIATION; TRANSLATION REGULATION; VIRUS CELL INTERACTION; VIRUS GENE;

DNA VIRUSES; RNA VIRUSES;

EID: 0037333760     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(03)00029-X     Document Type: Review

References (65)

1. Gale M. Jr, et al. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:2000;239-280.
2. Hershey J.W.B., Merrick W.C. Pathway and mechanism of initiation of protein synthesis. Hershey J.W.B., et al. Translational Regulation of Gene Expression. 2000;33-88 Cold Spring Harbor Laboratory Press.
3. Gingras A.-C., et al. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:1999;913-963.
4. Tarun S.Z., et al. Translation initiation factor eIF-4G mediates in vitro polyA tail dependent translation. Proc. Natl. Acad. Sci. U. S. A. 94:1997;9046-9051.
5. Imataka H., et al. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J. 17:1998;7480-7489.
6. Gradi A., et al. A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell. Biol. 18:1998;334-342.
7. Byrd M.P., et al. Generation of multiple isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons. Mol. Cell. Biol. 22:2002;4499-4511.
8. Pyronnet S., et al. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E. EMBO J. 18:1999;270-279.
9. Waskiewicz A.J., et al. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol. Cell. Biol. 19:1999;1871-1880.
10. Pestova T.V., et al. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7029-7036.
11. Kozak M. The scanning model for translation: an update. J. Cell Biol. 108:1989;229-241.
12. Pe'ery, T. and Mathews, M.B. (2000) Viral translational strategies and host defense mechanisms. In Translational Control of Gene expression (Vol. Monograph 39) (Hershey, J.W.B. et al., eds), pp. 371-424, Cold Spring Harbor Laboratory Press.
13. Schneider R.J. Adenovirus inhibition of cellular protein synthesis and preferential translation of viral mRNAs. Hershey J.W.B., et al. Translational Regulation. 2000;901-914 Cold Spring Harbor Laboratory Press.
14. Clemens M.J. The small RNAs of Epstein-Barr virus. Mol. Biol. Rep. 17:1993;81-92.
15. Nanbo A., et al. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J. 21:2002;954-965.
16. Gunnery S., et al. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded RNA activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 87:1990;8687-8691.
17. Maitra R.K., et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 204:1994;823-827.
18. Mulvey M., et al. A herpesvirus ribosome associated RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function. J. Virol. 73:1999;3375-3385.
19. Khoo D., et al. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation. J. Virol. 76:2002;11971-11981.
20. Beattie E., et al. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:1995;499-505.
21. Lloyd R.M., Shatkin A.J. Translational stimulation by reovirus polypeptide 3: substitution for VAI RNA and inhibition of phosphorylation of the α subunit of eukaryotic initiation factor 2. J. Virol. 66:1992;6878-6884.
22. Salvatore M., et al. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76:2002;1206-1212.
23. Romano P.R., et al. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 18:1998;7304-7316.
24. Peters G.A., et al. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 76:2002;11054-11064.
25. Cassady K.A., Gross M. The herpes simplex virus type 1 US11 protein interacts with protein kinase R in infected cells and requires a 30 amino acid sequence adjacent to a kinase substrate domain. J. Virol. 76:2002;2029-2035.
26. Poppers J., et al. Identification of a lytic Epstein-Barr virus gene product that can regulate PKR activation. J. Virol. 77:2003;228-236.
27. Burysek L., Pitha P.M. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-standed RNA-activated protein kinase. J. Virol. 75:2001;2345-2352.
28. He B., et al. The γ(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 94:1997;843-848.
29. Carroll K., et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 α-specific protein kinase. J. Biol. Chem. 268:1993;12837-12842.
30. Child S.J., et al. Complementation of Vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human Cytomegalovirus. J. Virol. 76:2002;4912-4918.
31. Gale M. Jr, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18:1998;5208-5218.
32. Noguchi T., et al. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol. Immunol. 45:2001;829-840.
33. He Y., et al. Regulation of mRNA translation and cellular signaling by hepatitis C virus NS5A nonstructural protein. J. Virol. 75:2001;5090-5098.
34. Pflugheber J., et al. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4650-4655.
35. Polyak S.J., et al. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology. 29:1999;1262-1271.
36. Francois C., et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74:2000;5587-5596.
37. Blight K.J., et al. Efficient initiation of HCV RNA replication in cell culture. Science. 290:2000;1972-1975.
38. Taylor D.R., et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science. 285:1999;107-110.
39. Taylor D.R., et al. Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J. Virol. 75:2001;1265-1273.
40. Pavio N., et al. Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J. Virol. 76:2002;1265-1272.
41. Fernandez J., et al. Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2α J. Biol. Chem. 277:2002;19198-19205.
42. Ali I.K., et al. Truncated initiation factor eIF4G lacking an eIF4E binding site can support capped mRNA translation. EMBO J. 20:2001;4233-4242.
43. Joachims M., et al. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J. Virol. 73:1999;718-727.
44. Kerekatte V., et al. Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? J. Virol. 73:1999;709-717.
45. Gingras A.-C., et al. Activation of the translational suppressor 4E-BP-1 following infection with encephalomyocarditis virus and poliovirus. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5578-5583.
46. Hellen C.U., Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15:2001;1593-1612.
47. Pelletier J., Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:1988;320-325.
48. Jang S.K., et al. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:1988;2636-2643.
49. Chen C.Y., Sarnow P. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 268:1995;415-417.
50. Pestova T.V., et al. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 12:1998;67-83.
51. Pause A., et al. Dominant negative mutants of mammalian intiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 13:1994;1205-1215.
52. Piron M., et al. Identification of the RNA-binding, dimerization, and eIF4GI-binding domains of rotavirus nonstructural protein NSP3. J. Virol. 73:1999;5411-5421.
53. Aragon T., et al. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 20:2000;6259-6268.
54. Park Y.W., et al. Regulation of eukaryotic protein synthesis: selective influenza viral mRNA translation is mediated by the cellular RNA-binding protein GRSF-1. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6694-6699.
55. Feigenblum D., Schneider R.J. Modification of eukaryotic initiation factor 4F during infection by influenza virus. J. Virol. 67:1993;3027-3035.
56. Roizman B., Knipe D.M. Herpes simplex viruses and their replication. Knipe D.M., Howley P. 4th edn Field's Virology. Vol. 2:2001;2399-2460 Lippincott.
57. Read G.S. Control of mRNA stability during herpes simplex virus infections. Harford J.B., Morris D.R. mRNA metabolism and Post-Transcriptional Gene Regulation. 1997;311-321 Wiley-Liss.
58. Everly D.N. Jr, et al. mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease. J. Virol. 76:2002;8560-8571.
59. Feng P., et al. mRNA decay during herpesvirus infections: interaction between a putative viral nuclease and a cellular translation factor. J. Virol. 75:2001;10272-10280.
60. Cuesta R., et al. Adenovirus specific translation by selective disassembly of cap-initiation complex. EMBO J. 19:2000;3465-3474.
61. Yueh A., Schneider R.J. Selective translation by ribosome jumping in adenovirus infected and heat shocked cells. Genes Dev. 10:1996;1557-1567.
62. Yueh A., Schneider R.J. Translation by ribosome shunting on adenovirus and Hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev. 14:2000;414-421.
63. Hohn T., et al. Ribosome shunting in eukaryotes: what the viruses tell me. Bailley-Serres J., Gallie D.R., et al. A Look Beyond Transcription: Mechanisms Determining mRNA Stability and Translation in Plants. 1998;84-95 American Soc. Plant Physiol.
64. Latorre P., et al. Sendai virus Y proteins are initiated by a ribosomal shunt. Mol. Cell. Biol. 18:1998;5021-5031.
65. Remm M., et al. Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism. J. Virol. 73:1999;3062-3070.